2026年6月最新影响因子数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
体验更多LetPub AI科研工具 >> | |
| 近期推荐： | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 热 Springer Nature特刊征稿 | 新 已发表SCI？是时候来Springer出书了！ |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Translational Breast Cancer Research TRANSL BREAST CANCER （此期刊被最新的JCR期刊ESCI收录） LetPub评分 0.0
50人评分
我要评分
声誉 0.0 影响力 0.0 速度 0.0 | |||||||||||||||||||||
| 期刊ISSN | 2218-6778 | 安装APP，查看期刊最新消息
| ||||||||||||||||||||
| 2025-2026最新IF （数据来源于网友提供） | 注册或登录后，查看IF | |||||||||||||||||||||
| 实时影响因子 | - | |||||||||||||||||||||
| 2025-2026自引率 | 2.6%点击查看自引率趋势图 | |||||||||||||||||||||
| 五年IF （数据来源于网友提供） | 2.501数据由网友[星宸]收集提供 | |||||||||||||||||||||
| h-index | 暂无h-index数据 | |||||||||||||||||||||
| CiteScore （ 2026年6月最新版） |
| |||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||
| 期刊官方网站 | ||||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||
| 期刊投稿网址 | ||||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Efficacy and safety of T-DXd in patients with HER2-positive and HER2-low metastatic breast cancer: a real-world study Author: Lu, Rongrong; Zha, Mengyao; Cao, Kai; Yong, Jiaqi; Li, Wei Journal: TRANSLATIONAL BREAST CANCER RESEARCH. 2026; Vol. , Issue , pp. -. DOI: 10.21037/tbcr-25-53 The efficacy and safety of metronomic vinorelbine combined with anlotinib in HER2-negative advanced breast cancer: a prospective, single-arm clinical study Author: Wang, Xinli; Yang, Ting; Zhang, Junmei; Yang, Jin; Gong, Ruizhi; Liu, Shusong; Xue, Yan Journal: TRANSLATIONAL BREAST CANCER RESEARCH. 2026; Vol. , Issue , pp. -. DOI: 10.21037/tbcr-25-48 Radiotherapeutic management of brain metastases in patients with breast cancer: a narrative review Author: Sun, Bing; Yue, Jinbo Journal: TRANSLATIONAL BREAST CANCER RESEARCH. 2026; Vol. , Issue , pp. -. DOI: 10.21037/tbcr-25-39 Eligibility for adjuvant CDK4/6 inhibitors in HR+/HER2- early breast cancer: insights from a large cohort in central south China Author: Wu, Jianmin; Zhao, Ziru; Li, Mengxi; Cao, Jing; Zhang, Kejing Journal: TRANSLATIONAL BREAST CANCER RESEARCH. 2026; Vol. , Issue , pp. -. DOI: 10.21037/tbcr-25-27 | |||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足Translational Breast Cancer Research的语言要求，还能让Translational Breast Cancer Research编辑和审稿人得到更好的审稿体验，让稿件最大限度地被Translational Breast Cancer Research编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||
| 通讯方式 | ||||||||||||||||||||||
| 出版商 | AME Publishing Company | |||||||||||||||||||||
| 涉及的研究方向 | ONCOLOGY- | |||||||||||||||||||||
| 出版国家或地区 | ||||||||||||||||||||||
| 出版语言 | ||||||||||||||||||||||
| 出版周期 | ||||||||||||||||||||||
| 出版年份 | 0 | |||||||||||||||||||||
| 年文章数 | 31点击查看年文章数趋势图 | |||||||||||||||||||||
| Gold OA文章占比 | 79.07% | |||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 38.71% | |||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版：不在预警名单中 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||
  | ||||||||||||||||||||||
| 《新锐期刊分区表》 （ 2026年3月发布） | 点击查看期刊分区表趋势图
| |||||||||||||||||||||
| 期刊分区表 （ 2025年3月升级版） | （没有被2025年的期刊分区表收录，仅供参考） | |||||||||||||||||||||
| 期刊分区表 （ 2023年12月旧的升级版） | （没有被旧的期刊分区表收录，仅供参考） | |||||||||||||||||||||
| SCI期刊收录coverage | Emerging Sources Citation Index (ESCI) Scopus (CiteScore) | |||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2218-6778%5BISSN%5D | |||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： | |||||||||||||||||||||
| 平均录用比例 | 网友分享经验： | |||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在Translational Breast Cancer Research顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Efficacy and safety of T-DXd in patients with HER2-positive and HER2-low metastatic breast cancer: a real-world study Author: Lu, Rongrong; Zha, Mengyao; Cao, Kai; Yong, Jiaqi; Li, Wei Journal: TRANSLATIONAL BREAST CANCER RESEARCH. 2026; Vol. , Issue , pp. -. DOI: 10.21037/tbcr-25-53 DOI |
| 2. | The efficacy and safety of metronomic vinorelbine combined with anlotinib in HER2-negative advanced breast cancer: a prospective, single-arm clinical study Author: Wang, Xinli; Yang, Ting; Zhang, Junmei; Yang, Jin; Gong, Ruizhi; Liu, Shusong; Xue, Yan Journal: TRANSLATIONAL BREAST CANCER RESEARCH. 2026; Vol. , Issue , pp. -. DOI: 10.21037/tbcr-25-48 PubMed DOI |
| 3. | Radiotherapeutic management of brain metastases in patients with breast cancer: a narrative review Author: Sun, Bing; Yue, Jinbo Journal: TRANSLATIONAL BREAST CANCER RESEARCH. 2026; Vol. , Issue , pp. -. DOI: 10.21037/tbcr-25-39 DOI |
| 4. | Eligibility for adjuvant CDK4/6 inhibitors in HR+/HER2- early breast cancer: insights from a large cohort in central south China Author: Wu, Jianmin; Zhao, Ziru; Li, Mengxi; Cao, Jing; Zhang, Kejing Journal: TRANSLATIONAL BREAST CANCER RESEARCH. 2026; Vol. , Issue , pp. -. DOI: 10.21037/tbcr-25-27 DOI |
| 5. | Prognostic value of RecurIndex in differentiating HER2-low from HER2-negative early-stage breast cancer: a comprehensive clinicopathologic and molecular analysis in Chinese patients Author: Zhang, Shuo; Hui, Tianli; Gao, Wei; Shi, Jiajie; Cheng, Meng; Wang, Mengxiao; Chen, Dongsheng; Zhang, Xing; Tan, Yuan; Geng, Cuizhi Journal: TRANSLATIONAL BREAST CANCER RESEARCH. 2026; Vol. 7, Issue , pp. -. DOI: 10.21037/tbcr-25-54 PubMed DOI |
| 6. | Chinese expert consensus on endocrine therapy for breast cancer (2026 edition) Author: Yuan, Yang; Yin, Yongmei; Wang, Shu; Liu, Yueping; Yang, Jin; Yan, Min; Mo, Xueli; Pan, Yueyin; Wang, Xiaojia; Wang, Haibo; Li, Jianbin; Wang, Shusen; Wu, Jiong; Song, Erwei; Jiang, Zefei Journal: TRANSLATIONAL BREAST CANCER RESEARCH. 2026; Vol. 7, Issue , pp. -. DOI: 10.21037/tbcr-2025-1-71 PubMed DOI |
| 7. | The preliminary study on the effect of PSEN1 on the proliferation and invasion of breast cancer cells Author: Yang, Miao; Zou, Jia-Qun; Yang, Wei Journal: TRANSLATIONAL BREAST CANCER RESEARCH. 2026; Vol. 7, Issue , pp. -. DOI: 10.21037/tbcr-25-42 PubMed DOI |
| 8. | Real-world efficacy and prognostic factors of CDK4/6 inhibitors in HR+/HER2- metastatic breast cancer: a multicenter retrospective study from the Dongting Lake region of China Author: Liu, Binliang; Wu, Tao; Lu, Kaili; Chen, Jun; Zhou, Qiang; Liu, Liping; Tian, Can; Hu, Zhe-Yu; Tang, Yu; Ouyang, Quchang; Xie, Ning Journal: TRANSLATIONAL BREAST CANCER RESEARCH. 2026; Vol. 7, Issue , pp. -. DOI: 10.21037/tbcr-25-37 PubMed DOI |
| 9. | Recent advances and updated highlights in breast cancer pathologic diagnosis: a narrative review Author: Liu, Yueping Journal: TRANSLATIONAL BREAST CANCER RESEARCH. 2025; Vol. 6, Issue , pp. -. DOI: 10.21037/tbcr-24-27 PubMed DOI |
| 10. | Advances in antibody-drug conjugates in the treatment of advanced triple-negative breast cancer: a narrative review Author: Jiang, Kuikui; Wang, Shusen Journal: TRANSLATIONAL BREAST CANCER RESEARCH. 2025; Vol. 6, Issue , pp. -. DOI: 10.21037/tbcr-24-38 PubMed DOI |
|
|
  | ||||||||||||||||
|
投稿状态统计： 我要评分： | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验：共0条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
投稿信 (Cover Letter) 模板
